# Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test

> **NCT01426308** · — · COMPLETED · sponsor: **Illumina, Inc.** · enrollment: 900 (actual)

## Conditions studied

- Post-natal Cytogenetics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01426308
- **Lead sponsor:** Illumina, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2016-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426308, "Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01426308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*